M

Milestone Pharmaceuticals
D

MIST

0.79500
USD
0.01
(1.16%)
مغلق
حجم التداول
7,944
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
98,975,894

العنوان: Milestone Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.